Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.

Abstract:

:The role of angiogenesis inhibition in the antitumor activity of recombinant murine interleukin 12 (rmIL-12) was studied in K1735 murine melanomas, the growth of which is rapidly and markedly suppressed by rmIL-12 treatment. On the basis of the prediction that tumor ischemia should result from therapeutic angiogenesis inhibition, tumor cell hypoxia was evaluated as a marker of ischemia using the EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)aceta mide] approach. This method measures intracellular binding of the nitroimidazole EF5, which covalently binds to cellular macromolecules selectively under hypoxic conditions. Whereas 1 week of rmIL-12 treatment effectively inhibited K1735 cell-induced angiogenesis in Matrigel neovascularization assays, 2 weeks of treatment were needed before severe tumor cell hypoxia was detected in K1735 tumors. The hypoxia that developed was regional and localized to tumor areas distant from blood vessels. The great majority of severely hypoxic tumor cells were apoptotic, and in vitro studies indicated that the degree of hypoxia present within treated tumors was sufficient to trigger K1735 apoptosis. Tumor cell apoptosis was also prevalent in the first week of rmIL-12 treatment when few cells were hypoxic. In vitro studies indicated that this non-hypoxia-related apoptosis was induced directly by IFN-gamma produced in response to rmIL-12 administration. These studies reveal that rmIL-12 controls K1735 tumors initially by IFN-gamma-induced apoptosis and later by hypoxia-induced apoptosis. They also establish hypoxia as an expected result of tumor angiogenesis inhibition and a mediator of its therapeutic effect.

journal_name

Cancer Res

journal_title

Cancer research

authors

Gee MS,Koch CJ,Evans SM,Jenkins WT,Pletcher CH Jr,Moore JS,Koblish HK,Lee J,Lord EM,Trinchieri G,Lee WM

subject

Has Abstract

pub_date

1999-10-01 00:00:00

pages

4882-9

issue

19

eissn

0008-5472

issn

1538-7445

journal_volume

59

pub_type

杂志文章
  • 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.

    abstract::2-Methoxyestradiol (2ME(2)), a physiologic metabolite of 17beta-estradiol (estrogen), has emerged as a promising cancer therapy because of its potent growth-inhibitory and proapoptotic effects on both endothelial and tumor cells. 2ME(2) also suppresses osteoclast differentiation and induces apoptosis of mature osteocl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1362

    authors: Cicek M,Iwaniec UT,Goblirsch MJ,Vrabel A,Ruan M,Clohisy DR,Turner RR,Oursler MJ

    更新日期:2007-11-01 00:00:00

  • Comparison of the malignant potential of 10T 1/2 cells and transformants with their survival responses to hyperthermia and to amphotericin B1.

    abstract::Several responses of 10T 1/2 cells and of cells from strains transformed by X-irradiation or by methylcholanthrene exposure were examined. Malignant potential, as determined by the ability of the cells to initiate tumors in syngeneic hosts, either normal or rendered immunodeficient, varied by a factor of 10(6). The gr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hahn GM

    更新日期:1980-10-01 00:00:00

  • Sensitivities of peripheral lymphocytes from healthy humans to induction of sister chromatid exchanges by chemicals.

    abstract::The spontaneous sister chromatid exchanges (SCEs) and SCEs induced by 50 microM methyl methanesulfonate, 1 microM 4-nitroquinoline 1-oxide, and 5 microM 3-amino-1-methyl-5H-pyrido[4,3-b]indole were examined in phytohemagglutinin-activated peripheral lymphocytes from 53 healthy adult donors. The means of the mean spont...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Oikawa A,Sakai S,Horaguchi K,Tohda H

    更新日期:1983-01-01 00:00:00

  • ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

    abstract::Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1199

    authors: Kalashnikova EV,Revenko AS,Gemo AT,Andrews NP,Tepper CG,Zou JX,Cardiff RD,Borowsky AD,Chen HW

    更新日期:2010-11-15 00:00:00

  • Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells.

    abstract::Multiple myeloma is a B-cell malignancy for which no curative therapies exist to date, despite enormous research efforts. The remarkable activity of the proteasome inhibitor bortezomib (PS-341, Velcade) observed in clinical trials of patients with relapsed refractory myeloma has led to investigations of the role of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0506

    authors: Altun M,Galardy PJ,Shringarpure R,Hideshima T,LeBlanc R,Anderson KC,Ploegh HL,Kessler BM

    更新日期:2005-09-01 00:00:00

  • The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.

    abstract::p51/p63 is a novel p53 homologue that has been shown to act as a transcriptional activator through the p53-binding sequence of the p21/WAF1 promoter and to induce apoptosis when it is expressed transiently in a human tumor cell line. We developed transcription assay systems for these two related genes in both Saccharo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shimada A,Kato S,Enjo K,Osada M,Ikawa Y,Kohno K,Obinata M,Kanamaru R,Ikawa S,Ishioka C

    更新日期:1999-06-15 00:00:00

  • Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.

    abstract::Xeroderma pigmentosum variant (XPV) patients with mutations in the DNA polymerase eta (pol eta) gene are hypersensitive to sunlight and have greatly increased susceptibility to sunlight-induced skin cancer. Consistent with the ability of Pol eta to efficiently bypass UV light-induced cyclobutane pyrimidine dimers, XPV...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1862

    authors: Lin Q,Clark AB,McCulloch SD,Yuan T,Bronson RT,Kunkel TA,Kucherlapati R

    更新日期:2006-01-01 00:00:00

  • Cross-linkage of nucleophosmin in tumor cells by nitrogen mustard.

    abstract::Mouse leukemia (P388) cells were incubated in cell culture medium containing nitrogen mustard [2-chloro-N-(2-chloroethyl)-N-methylethanamine] for 4 h. The nucleophosmin immunoband with a molecular weight of 37,000 (p37; other molecular weights are similarly designated) was observed in both control and nitrogen mustard...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chan PK

    更新日期:1989-06-15 00:00:00

  • Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.

    abstract::We examined patterns of covalent modifications of DNA produced in rat liver after exposure to single and multiple doses of aflatoxin B1. The principal product, previously identified as 2,3-dihydro-3-hydroxy(N7-guanyl) aflatoxin B1, was removed rapidly from liver DNA in vivo after a 0.6-mg/kg dose was administered i.p....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Croy RG,Wogan GN

    更新日期:1981-01-01 00:00:00

  • Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

    abstract::Somatostatin receptors (SSTR) are highly expressed in well-differentiated neuroendocrine tumors (NET). Octreotide, an SSTR agonist, has been used to suppress the production of vasoactive hormones and relieve symptoms of hormone hypersecretion with functional NETs. In a clinical trial, an empiric dose of octreotide tre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1199

    authors: Heidari P,Wehrenberg-Klee E,Habibollahi P,Yokell D,Kulke M,Mahmood U

    更新日期:2013-12-01 00:00:00

  • Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.

    abstract::Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, is a newly synthesized, water-soluble nitrosourea antitumor agent that is active against L1210 leukemia in mice. A 701% and a 401% increase in life-span were attained with a dose that was lethal to 10% of the animals (15 to 20 mg/kg, i.p.) in mice t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Anderson T,McMenamin MG,Schein PS

    更新日期:1975-03-01 00:00:00

  • Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.

    abstract::Exposures to carcinogens present in the diet, in cigarette smoke, or in the environment have been associated with increased risk of bladder and colorectal cancer. The aromatic amines and their metabolites, a class of carcinogen implicated in these exposures, can be N- or O-acetylated by the NAT1 and NAT2 enzymes. Acet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bell DA,Badawi AF,Lang NP,Ilett KF,Kadlubar FF,Hirvonen A

    更新日期:1995-11-15 00:00:00

  • Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.

    abstract::Ewing sarcoma is a rare but aggressive disease most common in young adults. This cancer is driven by a unique chimeric fusion oncogene but targeted strategies have been elusive. Here we report the identification of the protein kinase PKC-ß (PRKCB) as a disease-specific druggable target for treatment of Ewing sarcoma. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0371

    authors: Surdez D,Benetkiewicz M,Perrin V,Han ZY,Pierron G,Ballet S,Lamoureux F,Rédini F,Decouvelaere AV,Daudigeos-Dubus E,Geoerger B,de Pinieux G,Delattre O,Tirode F

    更新日期:2012-09-01 00:00:00

  • CMAP: a novel cystatin-like gene involved in liver metastasis.

    abstract::A novel metastasis-associated gene was identified with a differential display system in murine carcinoma cells showing a high rate of metastasis to the liver. A human homologue was also identified using a PCR-based strategy. The protein coded by this gene was named cystatin-like metastasis-associated protein (CMAP) an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morita M,Yoshiuchi N,Arakawa H,Nishimura S

    更新日期:1999-01-01 00:00:00

  • Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.

    abstract::Successful antiestrogen treatment in patients with tamoxifen-responsive breast tumors is often followed by an outgrowth of tumors cells that are antiestrogen resistant, implying that estrogen-dependent tumors can become estrogen-independent. In an effect to mimic this progression, we have transfected fibroblast growth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McLeskey SW,Kurebayashi J,Honig SF,Zwiebel J,Lippman ME,Dickson RB,Kern FG

    更新日期:1993-05-01 00:00:00

  • Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.

    abstract::Antiangiogenic therapy is efficacious in metastatic renal cell carcinoma (mRCC). However, the ability of antiangiogenic drugs to delay tumor progression and extend survival is limited, due to either innate or acquired drug resistance. Furthermore, there are currently no validated biomarkers that predict which mRCC pat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0248

    authors: Robinson SP,Boult JKR,Vasudev NS,Reynolds AR

    更新日期:2017-08-01 00:00:00

  • Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.

    abstract::Ependymomas and astrocytomas commonly have allelic losses of chromosome 22q, which suggests the presence of a glioma tumor suppressor gene on 22q. A candidate tumor suppressor gene on 22q is the neurofibromatosis 2 (NF2) gene since NF2 patients have an increased susceptibility to ependymomas and astrocytomas. Using si...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rubio MP,Correa KM,Ramesh V,MacCollin MM,Jacoby LB,von Deimling A,Gusella JF,Louis DN

    更新日期:1994-01-01 00:00:00

  • Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration.

    abstract::Dysregulation of Wnt/β-catenin signaling is frequently observed in human gastric cancer. Elucidation of the tumor immune microenvironment is essential for understanding tumorigenesis and for the development of immunotherapeutic strategies. However, it remains unclear how β-catenin signaling regulates the tumor immune ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3074

    authors: Ji L,Qian W,Gui L,Ji Z,Yin P,Lin GN,Wang Y,Ma B,Gao WQ

    更新日期:2020-05-15 00:00:00

  • Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes.

    abstract::Environmental and occupational exposure to arsenite is associated with an increased risk of human cancers, including skin, urinary bladder, and respiratory tract cancers. Although much evidence suggests that alterations in cell cycle machinery are implicated in the carcinogenic effect of arsenite, the molecular mechan...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0469

    authors: Ouyang W,Ma Q,Li J,Zhang D,Liu ZG,Rustgi AK,Huang C

    更新日期:2005-10-15 00:00:00

  • Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

    abstract::Cyclooxygenase-2 is a valid target for cancer prevention and treatment. This has been shown in preclinical and clinical cancer prevention studies by using a cyclooxygenase-2 inhibitor, celecoxib. When used in a randomized cancer prevention clinical trial on patients with the inherited autosomal dominant condition, fam...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-3754

    authors: Xiao Z,Luke BT,Izmirlian G,Umar A,Lynch PM,Phillips RK,Patterson S,Conrads TP,Veenstra TD,Greenwald P,Hawk ET,Ali IU

    更新日期:2004-04-15 00:00:00

  • Components of hematoporphyrin derivatives and their tumor-localizing capacity.

    abstract::Hematoporphyrin derivative (HPD), a complex mixture of porphyrins derived from hematoporphyrin, has been used for localization and photoradiation therapy of tumors. In this report, we describe characterization of HPD and of its component porphyrins by reverse-phase thin-layer chromatography. Uptake of major HPD compon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kessel D

    更新日期:1982-05-01 00:00:00

  • Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.

    abstract::A new form of therapy of experimental tumors, utilizing lymphokine-activated killer (LAK) cells and high doses of interleukin 2, has recently been applied in the treatment of human neoplasms. Severe side effects, suggestive of a diffuse vascular injury of unknown etiology, have prevented a more widespread application ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kotasek D,Vercellotti GM,Ochoa AC,Bach FH,White JG,Jacob HS

    更新日期:1988-10-01 00:00:00

  • Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.

    abstract::The human inducible nitric oxide synthase (hiNOS) gene is regulated by nuclear factor kappaB (NF-kappaB) and has recently been shown to be a target of the Wnt/beta-catenin pathway. In this study, we tested the hypothesis that Wnt/beta-catenin signaling might regulate cytokine- or tumor necrosis factor alpha (TNFalpha)...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0014

    authors: Du Q,Zhang X,Cardinal J,Cao Z,Guo Z,Shao L,Geller DA

    更新日期:2009-05-01 00:00:00

  • In vitro chemical mutagenesis and viral transformation of a human endothelial cell strain.

    abstract::We have established and characterized a diploid cell strain of normal human endothelial cells, RuBa 7E. RuBa 7E cells have an average cloning efficiency of 20% during early passages and undergo approximately 50 doublings in vitro before senescing spontaneously. At confluence, RuBa 7E cells form a homogeneous monolayer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reznikoff CA,DeMars R

    更新日期:1981-03-01 00:00:00

  • SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.

    abstract::SOX9 is a transcription factor that plays a critical role in the development of multiple tissues. We previously reported that SOX9 in normal human adult prostate was restricted to basal epithelium. SOX9 was also expressed in a subset of prostate cancer (PCa) cells and was increased in relapsed hormone-refractory PCa. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5915

    authors: Wang H,Leav I,Ibaragi S,Wegner M,Hu GF,Lu ML,Balk SP,Yuan X

    更新日期:2008-03-15 00:00:00

  • Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography.

    abstract::To improve tumor:tissue ratios in immunoscintigraphy, a three-step targeting method has been developed. The reagents used were (a) a radioactive, low molecular weight chelate prepared from ionic gallium and a phenolic polyaminocarboxylic acid, which can be labeled either with the single-photon emitter 67Ga or with the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schuhmacher J,Klivényi G,Matys R,Stadler M,Regiert T,Hauser H,Doll J,Maier-Borst W,Zöller M

    更新日期:1995-01-01 00:00:00

  • Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.

    abstract::Carcinoma cells can transition from an epithelial-to-mesenchymal differentiation state through a process known as epithelial-mesenchymal transition (EMT). The process of EMT is characterized by alterations in the pattern of gene expression and is associated with a loss of cell polarity, an increase in invasiveness, an...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-14-2824

    authors: Bogachek MV,De Andrade JP,Weigel RJ

    更新日期:2015-01-01 00:00:00

  • Lipid-dependent proliferation of pancreatic cancer cell lines.

    abstract::Capan 1, a human pancreatic cancer cell line, is routinely grown in 10% fetal calf serum (FCS). In order to characterize the factors needed for its proliferation, FCS was replaced by a synthetic serum (Ultroser G). For Capan 1 proliferation we found that Ultroser G was as efficient as FCS. A subfraction of Ultroser G ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Clerc P,Bensaadi N,Pradel P,Estival A,Clemente F,Vaysse N

    更新日期:1991-07-15 00:00:00

  • Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma.

    abstract::Data on biodistribution and pharmacokinetics of Na2B12H11SH are few and lack in standardization. This study comprises a uniform series of 10 patients with glioblastoma administered Na2B12H11SH i.v. 24 h before surgery at a dose level used in earlier therapeutical trials (75 mg/kg body weight). Boron concentrations in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Haselsberger K,Radner H,Pendl G

    更新日期:1994-12-15 00:00:00

  • Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.

    abstract::Tumor suppressor p53-dependent apoptosis is thought to be one of the most important tumor-suppressive functions in human tumorigenesis. However, whether the major mechanism underlying the p53-dependent apoptosis is transactivation dependent or independent remains unclear. Using 179 mutant p53s with diverse transcripti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2935

    authors: Kakudo Y,Shibata H,Otsuka K,Kato S,Ishioka C

    更新日期:2005-03-15 00:00:00